Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients [NA]

View source ↗

Summary

A clinical trial compares the efficacy of ampicillin/sulbactam versus cefoperazone/sulbactam for multidrug-resistant Acinetobacter baumannii infections in criti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulperazone (cefoperazone-sulbactam)
  • UNASYN (Ampicillin sodium and sulbactam sodium)

Snippet

Sponsor: Cairo University | Conditions: Acinetobacter Baumannii Infection | NA | Status: RECRUITING